↓ Skip to main content

Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study

Overview of attention for article published in Blood, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
33 news outlets
blogs
3 blogs
policy
2 policy sources
twitter
26 X users
patent
2 patents
wikipedia
1 Wikipedia page

Citations

dimensions_citation
234 Dimensions

Readers on

mendeley
232 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
Published in
Blood, December 2018
DOI 10.1182/blood-2018-09-876136
Pubmed ID
Authors

Jong Wook Lee, Flore Sicre de Fontbrune, Lily Wong Lee Lee, Viviani Pessoa, Sandra Gualandro, Wolfgang Füreder, Vadim Ptushkin, Scott T Rottinghaus, Lori Volles, Lori Shafner, Rasha Aguzzi, Rajendra Pradhan, Hubert Schrezenmeier, Anita Hill

X Demographics

X Demographics

The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 232 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 232 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 13%
Other 26 11%
Student > Bachelor 18 8%
Student > Doctoral Student 16 7%
Student > Ph. D. Student 14 6%
Other 27 12%
Unknown 100 43%
Readers by discipline Count As %
Medicine and Dentistry 52 22%
Pharmacology, Toxicology and Pharmaceutical Science 17 7%
Biochemistry, Genetics and Molecular Biology 15 6%
Nursing and Health Professions 12 5%
Unspecified 7 3%
Other 21 9%
Unknown 108 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 272. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2023.
All research outputs
#132,192
of 25,385,509 outputs
Outputs from Blood
#72
of 33,249 outputs
Outputs of similar age
#2,609
of 445,099 outputs
Outputs of similar age from Blood
#5
of 677 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 33,249 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,099 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 677 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.